Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,837 | 10,261 | 4,151 | 4,637 | 1,128 |
| Marketable Securities | 420 | 820 | 600 | 570 | 0 |
| Inventories | N/A | N/A | 56 | 45 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 57 |
| TOTAL | $10,402 | $11,302 | $4,974 | $5,482 | $1,427 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 88 | 88 | 30 | 19 | 0 |
| TOTAL | $88 | $88 | $30 | $19 | $N/A |
| Total Assets | $10,490 | $11,390 | $5,004 | $5,501 | $1,427 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2 | N/A |
| Accounts payable and accrued liabilities | 418 | 211 | 192 | 238 | 127 |
| TOTAL | $490 | $283 | $264 | $327 | $142 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1 | 4 |
| Deferred Revenues | 72 | 72 | 72 | 69 | N/A |
| TOTAL | $938 | $956 | $974 | $946 | $4 |
| Total Liabilities | $1,428 | $1,239 | $1,238 | $1,273 | $146 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,672 | 98,672 | 98,672 | 98,672 | 85,177 |
| Common Shares | 0 | 10 | 10 | 9 | 9 |
| Retained earnings | -3,263 | -2,174 | -8,559 | -8,097 | -5,762 |
| TOTAL | $9,062 | $10,151 | $3,766 | $4,228 | $1,281 |
| Total Liabilities And Equity | $10,490 | $11,390 | $5,004 | $5,501 | $1,427 |